Clinical Considerations When Introducing Sodium-Glucose Co-Transporter 2 Inhibition in Patients With Heart Failure

Background: In patients with heart failure (HF), discontinued medical therapy because of adverse events (AE) is associated with high mortality. Patients with type 2 diabetes mellitus (T2DM) treated with sodium-glucose co-transporter 2 inhibitors (SGLT2i) have a lower risk of HF, but AE sometimes occ...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Circ Rep
Hlavní autoři: Yazaki, Mayu, Nabeta, Takeru, Inomata, Takayuki, Maemura, Kenji, Ooki, Takumi, Fujita, Teppei, Iida, Yuichiro, Ikeda, Yuki, Ishii, Shunsuke, Naruke, Takashi, Ako, Junya
Médium: Artigo
Jazyk:Inglês
Vydáno: The Japanese Circulation Society 2019
Témata:
Original article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7929704/
https://ncbi.nlm.nih.gov/pubmed/33693174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1253/circrep.CR-19-0080
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky